STOCK TITAN
  1. Home
  2. Sec-filings
  3. CDIO
  4. [Form 4] Cardio Diagnostics Holdings, Inc. Insider Trading Activity

Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cardio Diagnostics Holdings, Inc. director Wendy J. Betts received a grant of stock options covering 2,854 shares of common stock. The options have an exercise price of $2.19 per share and expire on June 30, 2036. This is a compensation-related award, not an open-market trade, and brings her directly held option awards to a total of 12,367 underlying shares.

Positive

  • None.

Negative

  • None.
Insider Betts Wendy J
Role null
Type Security Shares Price Value
Grant/Award Stock Options (Right to Buy) 2,854 $2.19 $6K
Holdings After Transaction: Stock Options (Right to Buy) — 12,367 shares (Direct, null)
Footnotes (1)
Options granted 2,854 options Grant to director Wendy J. Betts on June 30, 2026
Exercise price $2.19 per share Exercise price of newly granted options
Expiration date June 30, 2036 Expiry of granted stock options
Total options after grant 12,367 options Total underlying shares following transaction
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
grant/award acquisition financial
"transaction_action: grant/award acquisition"
exercise price financial
"conversion_or_exercise_price: 2.1900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-30T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Betts Wendy J
(Last)(First)(Middle)
311 W. SUPERIOR ST., SUITE 444
C/O CARDIO DIAGNOSTICS HOLDINGS, INC.
(Street)
CHICAGO ILLINOIS 60654
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Cardio Diagnostics Holdings, Inc. [ CDIO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$2.1906/30/2026A2,85406/30/202606/30/2036Common Stock2,854$2.1912,367D
Explanation of Responses:
/s/Elisa Luqman as attorney-in-fact for Wendy Betts07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Cardio Diagnostics (CDIO) report for Wendy J. Betts?

Cardio Diagnostics reported that director Wendy J. Betts received a grant of 2,854 stock options. These derivative securities give her the right to buy an equal number of common shares under a compensation award, rather than through an open-market purchase or sale.

At what price were the new Cardio Diagnostics (CDIO) stock options granted to Wendy J. Betts?

The new stock options granted to Wendy J. Betts have an exercise price of $2.19 per share. This means she can purchase Cardio Diagnostics common stock at $2.19 for each option when exercising, subject to any applicable vesting and plan terms.

How many Cardio Diagnostics (CDIO) shares are covered by Wendy J. Betts’s stock options after this Form 4?

After this grant, Wendy J. Betts holds stock options covering 12,367 underlying shares. This total reflects her direct derivative holdings reported in the filing, including the newly awarded 2,854 options tied to Cardio Diagnostics common stock.

When do Wendy J. Betts’s newly granted Cardio Diagnostics (CDIO) stock options expire?

The newly granted stock options to Wendy J. Betts expire on June 30, 2036. She can choose to exercise them at the $2.19 per share exercise price any time allowed under the plan before that expiration date, subject to vesting conditions.

Was this Cardio Diagnostics (CDIO) Form 4 transaction an open-market buy or sell?

No, the Form 4 shows a grant or award acquisition of stock options, not an open-market trade. Wendy J. Betts received 2,854 options as compensation, so no common shares were bought or sold on the market in this transaction.